Median overall survival (OS) increased from 19.3 months with upfront immune checkpoint inhibition (ICI) to 41.3 months when a ...

FDA confirmed in a recent FDA Type B meeting under RMAT designation that the PROACT 1 Phase 3 study could be sufficient to support a full U.S. regulatory approval of rilparencel; ...

Participants were broken into two cohorts. The first cohort received one of three doses of PCRX-201. The second cohort received concurrent pretreatment with an intraarticular corticosteroid ...

Detailed price information for Igm Biosciences Inc (IGMS-Q) from The Globe and Mail including charting and trades.

Communication is key to a well-functioning school environment, and posters play a vital role in spreading information ...

Posters will be presented at the 2024 Annual Meeting of the ... By employing a multi-specific Switch-DARPin, Molecular Partners aims to bring additional dimensions of safety and potency to the ...

Spherix has been tracking the C3G market for over four years in both the U.S. and Europe. The studies have provided meaningful insights into physician perceptions of unmet needs and expectations for ...

A first-of-its-kind algorithm developed at Georgia Tech is helping scientists study interactions between electrons. This ...

Expects to deliver three Investigational New Drug (IND) applications in next three years based on next-generation ADC <a target=_blank href=http ...

The Santa Clarita Valley Chamber of Commerce has announced its annual 2025 Employment Law Update, taking place on Thursday, ...

A panel of professors discussed the evolution of artificial intelligence and its impact on education and research during the University of New Mexico's first-ever AI Summit on Monday. The panel of ...

To ensure businesses are prepared for the 2025 legislative landscape, the SCV Chamber is set to present the only local, ...